RETRACTED ARTICLE: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V. Damiano(University of Naples Federico II), Giampaolo Tortora(Università Cattolica del Sacro Cuore)
Cited by 18
Related Papers
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
|Journal for ImmunoTherapy of Cancer|2021|70
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs
|British Journal of Cancer|2008|27
RETRACTED ARTICLE: Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer
|British Journal of Cancer|2013|25
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice
|Journal of Experimental & Clinical Cancer Research|2025|6